This topic contains a solution. Click here to go to the answer

Author Question: The hormone secretin stimulates production of a buffering solution for the duodenum by the: a. ... (Read 7 times)

cdr_15

  • Hero Member
  • *****
  • Posts: 546
The hormone secretin stimulates production of a buffering solution for the duodenum by the:
 
  a. stomach.
  b. liver.
  c. pancreas.
  d. oxyntic cells.

Question 2

The substance that activates pepsinogen to pepsin is:
 
  a. bile.
  b. gastrin.
  c. secretin.
  d. hydrochloric acid.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

karmakat49

  • Sr. Member
  • ****
  • Posts: 369
Answer to Question 1

C

Answer to Question 2

D



cdr_15

  • Hero Member
  • *****
  • Posts: 546
Both answers were spot on, thank you once again




 

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library